高级检索
当前位置: 首页 > 详情页

Review fantastic medical implications of 3D-printing in liver surgeries, liver regeneration, liver transplantation and drug hepatotoxicity testing: A review

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ Engn, Affiliated Hosp, Coll Med, Dept Med Technol, Handan 056002, Peoples R China [2]Hebei Univ Engn, Coll Med, Handan 056002, Peoples R China [3]Hebei Univ Engn, Affiliated Hosp, Dept Clin Lab, Handan 056002, Peoples R China [4]Hebei Univ Engn, Affiliated Hosp, Dept Cardiol, Handan 056002, Peoples R China
出处:
ISSN:

关键词: 3D printing Liver constructs Surgical simulation Liver regeneration Liver transplantation Hepatotoxicity

摘要:
The epidemiological trend in liver diseases becomes more serious worldwide. Several recent articles published by International Journal of Surgery in 2018 particularly emphasized the encouraging clinical benefits of hepatectomy, liver regeneration and liver transplantation, however, there are still many technical bottlenecks underlying these therapeutic approaches. Remarkably, a few preliminary studies have shown some clues to the role of three-dimensional (3D) printing in improving traditional therapy for liver diseases. Here, we concisely elucidated the curative applications of 3D-printing (no cells) and 3D Bio-printing (with hepatic cells), such as 3D-printed patient-specific liver models and devices for medical education, surgical simulation, hepatectomy and liver transplantation, 3D Bio-printed hepatic constructs for liver regeneration and artificial liver, 3D-printed liver tissues for evaluating drug's hepatotoxicity, and so on. Briefly, 3D-printed liver models and bioactive tissues may facilitate a lot of key steps to cure liver disorders, predictably bringing promising clinical benefits. This work further provides novel insights into facilitating treatment of hepatic carcinoma, promoting liver regeneration both in vivo and in vitro, expanding transplantable liver resources, maximizing therapeutic efficacy as well as minimizing surgical complications, medical hepatotoxicity, operational time, economic costs, etc.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 外科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 外科
JCR分区:
出版当年[2018]版:
Q1 SURGERY
最新[2024]版:
Q1 SURGERY

影响因子: 最新[2024版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Hebei Univ Engn, Affiliated Hosp, Coll Med, Dept Med Technol, Handan 056002, Peoples R China [*1]Hebei Univ Engn, Affiliated Hosp, Coll Med, 81 & 83 Cong Tai Rd, Handan 056002, Hebei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Univ Engn, Affiliated Hosp, Coll Med, Dept Med Technol, Handan 056002, Peoples R China [4]Hebei Univ Engn, Affiliated Hosp, Dept Cardiol, Handan 056002, Peoples R China [*1]Hebei Univ Engn, Affiliated Hosp, Coll Med, 81 & 83 Cong Tai Rd, Handan 056002, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:19602 今日访问量:0 总访问量:1147 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号